SALMETEROL XINAFOATE

SALMETEROL XINAFOATE was reported 60266 times

SALMETEROL XINAFOATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 29 0.2231
1 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 32 0.1788
2 SLEEP DISORDER THERAPY 23 0.1162
3 CENTRAL NERVOUS SYSTEM MASS 11 0.1158
4 ANALGESIC THERAPY 35 0.1090
5 DRUG THERAPY 35 0.1032
6 ANTICOAGULANT THERAPY 29 0.1021
7 WALL MOTION SCORE INDEX ABNORMAL 11 0.1000
8 CEREBRAL ARTERY THROMBOSIS 47 0.0914
9 AIRWAY REMODELLING 11 0.0887
10 APPENDICOLITH 33 0.0853
11 BRAIN SCAN ABNORMAL 47 0.0842
12 VENTILATION PERFUSION MISMATCH 23 0.0819
13 STATUS ASTHMATICUS 37 0.0784
14 HOARSENESS 35 0.0726
15 CHRONIC OBSTRUCTIVE AIRWAYS DISEASE EXACERBATED 22 0.0634
16 CONGENITAL HIATUS HERNIA 12 0.0526
17 DYSPNOEA EXACERBATED 26 0.0505
18 TOTAL LUNG CAPACITY ABNORMAL 19 0.0488
19 MALIGNANT MELANOMA STAGE 0 10 0.0478
20 SPIROMETRY ABNORMAL 27 0.0452
21 NIKOLSKY'S SIGN 8 0.0442
22 MITE ALLERGY 26 0.0397
23 ATOPY 11 0.0396
24 MULTI-ORGAN DISORDER 72 0.0366
25 PULMONARY VASCULITIS 19 0.0353
26 HYPOAESTHESIA EYE 19 0.0322
27 MYCOTIC ALLERGY 27 0.0316
28 BACTEROIDES INFECTION 8 0.0307
29 CAPILLARITIS 8 0.0290
30 ALLERGIC GRANULOMATOUS ANGIITIS 21 0.0256
31 DUST ALLERGY 25 0.0255
32 BRONCHITIS ACUTE 10 0.0249
33 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 18 0.0246
34 INHALATION THERAPY 15 0.0238
35 PEAK EXPIRATORY FLOW RATE DECREASED 10 0.0227
36 OBSTRUCTIVE SLEEP APNOEA SYNDROME 31 0.0212
37 MYOGLOBIN BLOOD INCREASED 32 0.0209
38 POSTNASAL DRIP 11 0.0199
39 AREFLEXIA 52 0.0195
40 CONJUNCTIVITIS ALLERGIC 26 0.0175
41 BLOOD CORTISOL DECREASED 11 0.0172
42 ANOXIC ENCEPHALOPATHY 11 0.0171
43 HYPERPHOSPHATAEMIA 36 0.0167
44 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 34 0.0167
45 LUNG HYPERINFLATION 14 0.0163
46 PHARYNGOLARYNGEAL PAIN 86 0.0162
47 RESPIRATORY TRACT IRRITATION 16 0.0153
48 CARDIAC SEPTAL DEFECT 11 0.0153
49 EOSINOPHILIC MYOCARDITIS 11 0.0151
50 MICROANGIOPATHY 14 0.0149
51 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 13 0.0140
52 NASAL OEDEMA 25 0.0138
53 TEMPERATURE REGULATION DISORDER 30 0.0135
54 BLOOD PHOSPHORUS INCREASED 36 0.0132
55 RESPIRATORY SYMPTOM 37 0.0130
56 NEURITIS 20 0.0129
57 BRAIN NATRIURETIC PEPTIDE INCREASED 38 0.0123
58 PHARMACEUTICAL PRODUCT COMPLAINT 318 0.0122
59 OBSTRUCTIVE AIRWAYS DISORDER 134 0.0120
60 CANDIDIASIS 48 0.0120
61 TOTAL LUNG CAPACITY DECREASED 19 0.0119
62 URETHRAL PAIN 7 0.0118
63 BLOOD IMMUNOGLOBULIN E INCREASED 28 0.0116
64 BLISTER RUPTURE 8 0.0108
65 PLANTAR FASCIITIS 36 0.0107
66 MUSCLE CRAMP 19 0.0107
67 TONGUE INJURY 10 0.0107
68 CUSHING'S SYNDROME 7 0.0101
69 ELECTROMECHANICAL DISSOCIATION 8 0.0100
70 FORCED EXPIRATORY VOLUME DECREASED 28 0.0099
71 INCREASED BRONCHIAL SECRETION 25 0.0098
72 OXYGEN SUPPLEMENTATION 7 0.0095
73 INCREASED VISCOSITY OF BRONCHIAL SECRETION 6 0.0094
74 NORMOCHROMIC NORMOCYTIC ANAEMIA 27 0.0090
75 INCREASED UPPER AIRWAY SECRETION 46 0.0090
76 AORTIC STENOSIS 30 0.0086
77 ELECTROCARDIOGRAM ST-T CHANGE 6 0.0085
78 LUNG OPACITY 22 0.0083
79 HAEMOPHILUS INFECTION 8 0.0082
80 ASTHMA 919 0.0081
81 DELUSIONAL DISORDER, UNSPECIFIED TYPE 6 0.0080
82 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 40 0.0079
83 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
84 CALCULUS BLADDER 10 0.0073
85 MUCOUS MEMBRANE DISORDER 10 0.0073
86 MALNUTRITION 80 0.0071
87 ADRENAL SUPPRESSION 6 0.0071
88 ACUTE PRERENAL FAILURE 8 0.0069
89 SUPERINFECTION 10 0.0067
90 PLEURITIC PAIN 18 0.0065
91 OESOPHAGEAL SPASM 12 0.0065
92 WHEEZING 378 0.0064
93 HEMIPLEGIA 52 0.0062
94 BLOOD URIC ACID INCREASED 36 0.0062
95 BRONCHOSPASM 88 0.0062
96 PULMONARY GRANULOMA 7 0.0061
97 EOSINOPHILIC PNEUMONIA 19 0.0060
98 VENTRICULAR HYPOKINESIA 19 0.0059
99 CHRONIC SINUSITIS 22 0.0059
100 EYE HAEMORRHAGE 77 0.0058
101 SPUTUM DISCOLOURED 53 0.0056
102 VOCAL CORD DISORDER 11 0.0056
103 EOSINOPHIL COUNT DECREASED 13 0.0055
104 FOETAL DEATH 28 0.0054
105 FACIAL PARALYSIS 44 0.0052
106 EOSINOPHIL COUNT INCREASED 43 0.0052
107 EXTREMITY NECROSIS 9 0.0052
108 EMPHYSEMA 52 0.0051
109 ARTERIOSCLEROSIS CORONARY ARTERY 34 0.0051
110 PULMONARY FUNCTION TEST DECREASED 22 0.0050
111 VASCULAR PURPURA 7 0.0050
112 THYROID DISORDER 77 0.0050
113 BRONCHIAL HYPERREACTIVITY 6 0.0050
114 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 257 0.0049
115 ARTERIOSCLEROSIS 46 0.0049
116 BREATH SOUNDS ABNORMAL 24 0.0049
117 HYPERLIPIDAEMIA 57 0.0048
118 ORAL FUNGAL INFECTION 13 0.0047
119 LUNG NEOPLASM 20 0.0047
120 IRON DEFICIENCY 21 0.0047
121 ACUTE SINUSITIS 8 0.0046
122 FOOD ALLERGY 35 0.0045
123 SENSATION OF FOREIGN BODY 38 0.0045
124 ANGIONEUROTIC OEDEMA 12 0.0045
125 RALES 26 0.0045
126 LOBAR PNEUMONIA 8 0.0043
127 BRONCHIAL OBSTRUCTION 6 0.0043
128 ORAL CANDIDIASIS 56 0.0042
129 DEREALISATION 9 0.0042
130 APPENDICITIS 39 0.0042
131 FACIAL PALSY 9 0.0042
132 DYSPHONIA 240 0.0041
133 BRONCHITIS CHRONIC 10 0.0041
134 DIFFICULTY IN WALKING 14 0.0041
135 CHOKING SENSATION 22 0.0040
136 PROSTATITIS 12 0.0039
137 BLOOD PRESSURE IMMEASURABLE 6 0.0039
138 AORTIC ARTERIOSCLEROSIS 10 0.0039
139 BLOOD CALCIUM INCREASED 34 0.0039
140 BURSITIS 47 0.0039
141 EXOSTOSIS 35 0.0038
142 IDIOPATHIC THROMBOCYTOPENIC PURPURA 6 0.0038
143 PRODUCTIVE COUGH 180 0.0038
144 PULMONARY ALVEOLAR HAEMORRHAGE 21 0.0037
145 SPUTUM INCREASED 8 0.0037
146 NEUROLOGICAL SYMPTOM 21 0.0037
147 OROPHARYNGEAL DISCOMFORT 33 0.0036
148 CEREBROVASCULAR DISORDER 11 0.0036
149 PULMONARY CONGESTION 48 0.0036
150 COLONIC POLYP 6 0.0036
151 FULL BLOOD COUNT ABNORMAL 38 0.0036
152 ASTHMATIC CRISIS 13 0.0036
153 PERICARDIAL EFFUSION 81 0.0035
154 CHEST DISCOMFORT 357 0.0035
155 CERVICAL SPINAL STENOSIS 6 0.0035
156 PNEUMOTHORAX 55 0.0035
157 NODULE 45 0.0034
158 APHONIA 48 0.0034
159 SECRETION DISCHARGE 43 0.0034
160 VULVOVAGINAL DRYNESS 11 0.0034
161 KYPHOSIS 6 0.0034
162 HYPOPHOSPHATAEMIA 25 0.0034
163 COELIAC DISEASE 33 0.0034
164 DILATATION VENTRICULAR 7 0.0033
165 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 18 0.0033
166 PHARYNGEAL ERYTHEMA 7 0.0033
167 CORONARY ARTERY DISEASE 100 0.0033
168 BLOOD TEST ABNORMAL 46 0.0033
169 CHEST X-RAY ABNORMAL 10 0.0033
170 ISCHAEMIC CARDIOMYOPATHY 10 0.0033
171 NASAL POLYPS 16 0.0032
172 MYASTHENIA GRAVIS 26 0.0032
173 BRONCHOPNEUMONIA 11 0.0032
174 HAEMOPTYSIS 89 0.0032
175 VENTRICULAR HYPERTROPHY 8 0.0032
176 TROPONIN INCREASED 24 0.0032
177 ISCHAEMIC STROKE 56 0.0031
178 LYMPHADENOPATHY MEDIASTINAL 6 0.0031
179 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 53 0.0031
180 COMPUTERISED TOMOGRAM ABNORMAL 7 0.0031
181 LIPOMA 8 0.0031
182 CARDIOGENIC SHOCK 44 0.0031
183 VENTRICULAR FIBRILLATION 34 0.0031
184 TOOTH DISCOLOURATION 9 0.0031
185 EXPIRED DRUG ADMINISTERED 15 0.0030
186 METABOLIC ENCEPHALOPATHY 9 0.0030
187 RESPIRATORY DISTRESS 82 0.0030
188 BRONCHIECTASIS 20 0.0030
189 DYSPNOEA EXERTIONAL 111 0.0029
190 LACUNAR INFARCTION 7 0.0029
191 RHINITIS ALLERGIC 13 0.0029
192 DRY THROAT 29 0.0029
193 NON-CARDIAC CHEST PAIN 9 0.0028
194 HYPOXIA 100 0.0028
195 MIDDLE INSOMNIA 53 0.0028
196 PULMONARY FIBROSIS 54 0.0028
197 PSEUDOMONAS INFECTION 24 0.0028
198 RESPIRATORY ACIDOSIS 11 0.0028
199 ATELECTASIS 27 0.0028
200 LOW TURNOVER OSTEOPATHY 11 0.0028
201 LACTOSE INTOLERANCE 7 0.0027
202 LUNG INFILTRATION 24 0.0027
203 HYPERCHOLESTEROLAEMIA 26 0.0027
204 VISUAL DISTURBANCE 15 0.0026
205 RENAL FAILURE CHRONIC 20 0.0026
206 EOSINOPHILIA 45 0.0026
207 ANOREXIA 33 0.0026
208 BACTERIAL INFECTION 47 0.0025
209 STOMACH DISCOMFORT 13 0.0025
210 FACIAL BONES FRACTURE 9 0.0025
211 PULMONARY OEDEMA 109 0.0024
212 PRESCRIBED OVERDOSE 47 0.0024
213 THROAT IRRITATION 108 0.0024
214 VASCULITIS 28 0.0024
215 TRICUSPID VALVE INCOMPETENCE 19 0.0024
216 LUNG DISORDER 117 0.0024
217 SPINAL COLUMN STENOSIS 11 0.0023
218 HYPERCAPNIA 7 0.0023
219 ANGINA UNSTABLE 15 0.0023
220 WOUND SECRETION 9 0.0023
221 EXTRASYSTOLES 16 0.0023
222 GOUT 41 0.0023
223 SPINAL OSTEOARTHRITIS 20 0.0023
224 CARDIAC FAILURE CONGESTIVE 182 0.0023
225 RESPIRATORY TRACT INFECTION 59 0.0023
226 ULCER 36 0.0023
227 OESOPHAGEAL CANDIDIASIS 9 0.0023
228 LUNG INFECTION 35 0.0023
229 DIVERTICULUM 16 0.0022
230 BLOOD POTASSIUM ABNORMAL 6 0.0022
231 PRODUCT COMPLAINT 57 0.0022
232 DYSPNOEA 1269 0.0022
233 INVESTIGATION 7 0.0022
234 FOREIGN BODY IN THROAT 7 0.0022
235 ABDOMINAL ADHESIONS 7 0.0022
236 IMMUNODEFICIENCY 33 0.0022
237 TONGUE DISORDER 16 0.0022
238 BRONCHITIS 163 0.0022
239 ORTHOPNOEA 7 0.0022
240 DRY MOUTH 177 0.0022
241 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
242 CYSTIC FIBROSIS 12 0.0022
243 CYANOSIS 34 0.0022
244 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
245 PULMONARY MASS 32 0.0021
246 HYPOVENTILATION 7 0.0021
247 LUNG CONSOLIDATION 6 0.0021
248 RENAL CYST 17 0.0021
249 COUGH 597 0.0021
250 MITRAL VALVE INCOMPETENCE 24 0.0021
251 FAECAL INCONTINENCE 10 0.0021
252 ATRIOVENTRICULAR BLOCK FIRST DEGREE 9 0.0021
253 DIVERTICULUM INTESTINAL 9 0.0021
254 LUMBAR SPINAL STENOSIS 6 0.0021
255 MULTIPLE ALLERGIES 16 0.0020
256 STRESS FRACTURE 11 0.0020
257 CARDIOMEGALY 25 0.0020
258 CATHETERISATION CARDIAC 9 0.0020
259 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
260 CAROTID ARTERY STENOSIS 7 0.0020
261 RESPIRATORY FAILURE 146 0.0020
262 FEELING JITTERY 38 0.0020
263 CORONARY ARTERY STENOSIS 10 0.0020
264 ACUTE PULMONARY OEDEMA 11 0.0020
265 PRODUCT QUALITY ISSUE 266 0.0020
266 UPPER RESPIRATORY TRACT INFECTION 90 0.0019
267 SCOLIOSIS 12 0.0019
268 ASPIRATION 21 0.0019
269 VAGINAL INFECTION 9 0.0019
270 SLEEP TERROR 8 0.0019
271 ADRENAL INSUFFICIENCY 23 0.0019
272 AORTIC VALVE INCOMPETENCE 8 0.0019
273 LOOSE TOOTH 6 0.0019
274 CATARACT OPERATION 11 0.0019
275 ASPHYXIA 15 0.0018
276 TIC 10 0.0018
277 ORAL PAIN 41 0.0018
278 END STAGE RENAL DISEASE 33 0.0018
279 MUSCLE RUPTURE 7 0.0018
280 NECROSIS 10 0.0018
281 DEVICE USE ERROR 62 0.0018
282 INTENTIONAL UNDERDOSE 13 0.0018
283 HIATUS HERNIA 23 0.0018
284 CEREBRAL ATROPHY 7 0.0018
285 ARTERIOSPASM CORONARY 7 0.0017
286 GRANULOMA 6 0.0017
287 PRODUCT LABEL CONFUSION 10 0.0017
288 CHEST PAIN 317 0.0017
289 GOITRE 7 0.0017
290 SUDDEN DEATH 18 0.0017
291 BLOOD POTASSIUM DECREASED 51 0.0017
292 OBESITY 27 0.0017
293 PULSE ABSENT 8 0.0017
294 MULTI-ORGAN FAILURE 29 0.0017
295 SLEEP APNOEA SYNDROME 32 0.0017
296 APPARENT DEATH 6 0.0017
297 THROAT TIGHTNESS 45 0.0017
298 MOUTH ULCERATION 35 0.0017
299 RESPIRATORY TRACT CONGESTION 26 0.0016
300 CARDIAC MURMUR 14 0.0016
301 GENERALISED OEDEMA 20 0.0016
302 PHARYNGITIS 20 0.0016
303 TONGUE DISCOLOURATION 7 0.0016
304 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 74 0.0016
305 ORAL DISCOMFORT 22 0.0016
306 ACUTE CORONARY SYNDROME 13 0.0016
307 ILEUS PARALYTIC 7 0.0016
308 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
309 GINGIVAL DISORDER 6 0.0016
310 CEREBRAL ISCHAEMIA 8 0.0016
311 ARTHRITIS 121 0.0015
312 RESPIRATORY DISORDER 46 0.0015
313 DENTAL CARIES 17 0.0015
314 PALPITATIONS 179 0.0015
315 NEURALGIA 37 0.0015
316 BLOOD LACTATE DEHYDROGENASE INCREASED 24 0.0015
317 TOXIC EPIDERMAL NECROLYSIS 23 0.0015
318 ACUTE RESPIRATORY FAILURE 29 0.0015
319 MACULAR DEGENERATION 18 0.0015
320 CREATININE RENAL CLEARANCE DECREASED 6 0.0015
321 UMBILICAL HERNIA 7 0.0015
322 RHINITIS 12 0.0015
323 MUSCLE DISORDER 12 0.0015
324 GLOSSODYNIA 33 0.0015
325 RESPIRATORY RATE INCREASED 13 0.0015
326 ASCITES 43 0.0015
327 HEART RATE IRREGULAR 33 0.0015
328 LARYNGEAL OEDEMA 9 0.0015
329 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
330 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
331 RESPIRATION ABNORMAL 10 0.0014
332 HYPERTHERMIA 11 0.0014
333 NASAL DRYNESS 9 0.0014
334 CANDIDA INFECTION 24 0.0014
335 DRUG EXPOSURE DURING PREGNANCY 48 0.0014
336 GASTRITIS 37 0.0014
337 HYPONATRAEMIA 79 0.0014
338 PHOTOSENSITIVITY REACTION 23 0.0014
339 RENAL FAILURE ACUTE 59 0.0014
340 EXERCISE TOLERANCE DECREASED 8 0.0014
341 HEPATIC LESION 6 0.0014
342 HERPES SIMPLEX 9 0.0014
343 HEART RATE INCREASED 137 0.0014
344 LACERATION 13 0.0014
345 TOXIC ENCEPHALOPATHY 7 0.0014
346 PATHOLOGICAL FRACTURE 7 0.0014
347 IMMOBILE 6 0.0014
348 BLOOD CHOLESTEROL INCREASED 64 0.0014
349 INITIAL INSOMNIA 14 0.0014
350 DIABETES MELLITUS 104 0.0014
351 ORAL DISORDER 10 0.0014
352 PERIPHERAL VASCULAR DISORDER 7 0.0014
353 URINARY RETENTION 45 0.0013
354 PLEURISY 8 0.0013
355 SLEEP DISORDER 95 0.0013
356 RESPIRATORY ARREST 37 0.0013
357 CARDIO-RESPIRATORY ARREST 56 0.0013
358 SINUS TACHYCARDIA 19 0.0013
359 PROTHROMBIN TIME PROLONGED 8 0.0013
360 RENAL TUBULAR NECROSIS 13 0.0013
361 LIP DRY 12 0.0013
362 ECONOMIC PROBLEM 20 0.0013
363 ECCHYMOSIS 9 0.0013
364 VULVOVAGINAL BURNING SENSATION 8 0.0013
365 ATRIAL FIBRILLATION 127 0.0013
366 LARGE INTESTINE POLYP 9 0.0013
367 ANGINA PECTORIS 37 0.0013
368 NERVOUSNESS 67 0.0013
369 SINUSITIS 131 0.0013
370 PNEUMONIA 413 0.0013
371 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
372 RETCHING 27 0.0013
373 GESTATIONAL DIABETES 6 0.0013
374 ATRIAL FLUTTER 10 0.0013
375 VENTRICULAR EXTRASYSTOLES 13 0.0013
376 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60 0.0012
377 ANGIOPATHY 7 0.0012
378 GLAUCOMA 24 0.0012
379 ROTATOR CUFF SYNDROME 16 0.0012
380 TRANSIENT ISCHAEMIC ATTACK 42 0.0012
381 DRUG ADMINISTRATION ERROR 38 0.0012
382 THERAPEUTIC RESPONSE DECREASED 75 0.0012
383 PHARYNGEAL OEDEMA 19 0.0012
384 MAJOR DEPRESSION 9 0.0012
385 MICTURITION URGENCY 14 0.0012
386 REFUSAL OF TREATMENT BY PATIENT 8 0.0012
387 OEDEMA PERIPHERAL 149 0.0012
388 HYPOTHYROIDISM 39 0.0012
389 TENDON RUPTURE 15 0.0012
390 SPINAL COMPRESSION FRACTURE 10 0.0012
391 ABDOMINAL TENDERNESS 6 0.0012
392 HYPOVOLAEMIA 7 0.0012
393 HYPERTRIGLYCERIDAEMIA 7 0.0012
394 OESOPHAGITIS 13 0.0012
395 DIABETES MELLITUS INADEQUATE CONTROL 21 0.0012
396 MUSCLE ATROPHY 15 0.0012
397 DISEASE RECURRENCE 56 0.0012
398 MATERNAL DRUGS AFFECTING FOETUS 9 0.0012
399 WHITE BLOOD CELL COUNT INCREASED 45 0.0012
400 JOINT INJURY 25 0.0012
401 MUSCULOSKELETAL DISCOMFORT 20 0.0012
402 ACTIVITIES OF DAILY LIVING IMPAIRED 23 0.0012
403 LEUKOCYTOSIS 21 0.0012
404 TACHYCARDIA 103 0.0012
405 FAILURE TO THRIVE 6 0.0012
406 ACUTE MYOCARDIAL INFARCTION 34 0.0012
407 PULMONARY HYPERTENSION 24 0.0012
408 EYE INFECTION 13 0.0012
409 RASH ERYTHEMATOUS 55 0.0011
410 CARDIOMYOPATHY 17 0.0011
411 PSYCHOMOTOR HYPERACTIVITY 19 0.0011
412 OSTEOPOROSIS 47 0.0011
413 MYOCARDIAL ISCHAEMIA 13 0.0011
414 VIRAL INFECTION 38 0.0011
415 ARRHYTHMIA 54 0.0011
416 GROIN PAIN 10 0.0011
417 DUODENAL ULCER 8 0.0011
418 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
419 GINGIVAL PAIN 9 0.0011
420 HEPATOCELLULAR INJURY 16 0.0011
421 HYPERTENSION 239 0.0011
422 HYPOKALAEMIA 52 0.0011
423 FLUID RETENTION 57 0.0011
424 OSTEOPENIA 17 0.0011
425 GINGIVITIS 6 0.0011
426 CHEILITIS 6 0.0011
427 ANOSMIA 16 0.0011
428 SALIVARY HYPERSECRETION 11 0.0011
429 TREMOR 182 0.0011
430 NEUROLEPTIC MALIGNANT SYNDROME 13 0.0011
431 NEUROPATHY PERIPHERAL 104 0.0011
432 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
433 ILL-DEFINED DISORDER 66 0.0011
434 CARDIAC FLUTTER 7 0.0011
435 LOWER RESPIRATORY TRACT INFECTION 49 0.0011
436 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
437 BLOOD PRESSURE SYSTOLIC INCREASED 21 0.0011
438 CHOKING 21 0.0011
439 ATRIAL SEPTAL DEFECT 9 0.0011
440 BEDRIDDEN 14 0.0011
441 BLOOD SODIUM DECREASED 20 0.0011
442 MULTIPLE ORGAN DYSFUNCTION SYNDROME 30 0.0011
443 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
444 SPINAL DISORDER 10 0.0011
445 PULMONARY EMBOLISM 100 0.0011
446 BLOOD MAGNESIUM DECREASED 9 0.0010
447 BREAST MASS 7 0.0010
448 COLITIS ISCHAEMIC 7 0.0010
449 METASTASES TO LYMPH NODES 7 0.0010
450 HAEMOLYSIS 8 0.0010
451 ORTHOSTATIC HYPOTENSION 18 0.0010
452 OEDEMA 56 0.0010
453 BRONCHOPULMONARY ASPERGILLOSIS 8 0.0010
454 CONVULSION 59 0.0010
455 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 73 0.0010
456 MYALGIA 174 0.0010
457 HAEMATURIA 35 0.0010
458 COLD SWEAT 18 0.0010
459 RIB FRACTURE 21 0.0010
460 MUSCLE SPASMS 187 0.0010
461 BIPOLAR DISORDER 11 0.0010
462 BACK INJURY 11 0.0010
463 INTERVERTEBRAL DISC PROTRUSION 22 0.0010
464 GASTROOESOPHAGEAL REFLUX DISEASE 81 0.0010
465 SCIATICA 16 0.0010
466 DIPLOPIA 26 0.0010
467 CARDIAC DISORDER 93 0.0010
468 INTERNATIONAL NORMALISED RATIO INCREASED 28 0.0010
469 NEUTROPENIC SEPSIS 7 0.0010
470 IRON DEFICIENCY ANAEMIA 9 0.0010
471 DRUG INTOLERANCE 94 0.0010
472 CONCOMITANT DISEASE AGGRAVATED 6 0.0010
473 PARAESTHESIA ORAL 14 0.0010
474 MUSCULOSKELETAL CHEST PAIN 15 0.0010
475 EYE DISCHARGE 10 0.0010
476 AGEUSIA 24 0.0010
477 SWOLLEN TONGUE 30 0.0010
478 HAEMATOCRIT DECREASED 19 0.0010
479 SQUAMOUS CELL CARCINOMA 9 0.0010
480 BLOOD UREA INCREASED 16 0.0010
481 DRUG TOXICITY 13 0.0010
482 TYPE 2 DIABETES MELLITUS 32 0.0009
483 ABDOMINAL DISTENSION 99 0.0009
484 BRADYCARDIA 50 0.0009
485 GASTROENTERITIS VIRAL 17 0.0009
486 SPINAL PAIN 11 0.0009
487 MUSCULOSKELETAL PAIN 49 0.0009
488 DRUG INEFFECTIVE 1232 0.0009
489 BODY TEMPERATURE INCREASED 19 0.0009
490 SINUS BRADYCARDIA 9 0.0009
491 DYSGEUSIA 69 0.0009
492 PARANOIA 16 0.0009
493 INCOHERENT 6 0.0009
494 BLOOD ALKALINE PHOSPHATASE INCREASED 23 0.0009
495 INTENTIONAL PRODUCT MISUSE 81 0.0009
496 CATARACT 55 0.0009
497 SEASONAL ALLERGY 13 0.0009
498 WRIST FRACTURE 11 0.0009
499 ACIDOSIS 7 0.0009
500 HEPATIC CANCER 22 0.0009
501 ASPERGILLUS INFECTION 6 0.0009
502 NECK PAIN 51 0.0009
503 LIGAMENT SPRAIN 9 0.0009
504 HYPOGLYCAEMIA 44 0.0009
505 NOCTURIA 11 0.0009
506 PURPURA 8 0.0009
507 PLEURAL EFFUSION 55 0.0009
508 ADVERSE EVENT 83 0.0009
509 DYSURIA 33 0.0009
510 THROMBOSIS 72 0.0009
511 LACRIMATION INCREASED 27 0.0009
512 MYOSITIS 8 0.0009
513 BLOOD CREATININE INCREASED 58 0.0009
514 HEMIPARESIS 15 0.0009
515 OSTEOMYELITIS 16 0.0009
516 BLOOD ALBUMIN DECREASED 7 0.0009
517 BONE DISORDER 16 0.0009
518 CORONARY ARTERY OCCLUSION 12 0.0009
519 CELLULITIS 44 0.0009
520 OBSESSIVE-COMPULSIVE DISORDER 7 0.0009
521 MIOSIS 7 0.0009
522 PNEUMONIA BACTERIAL 8 0.0009
523 INCREASED TENDENCY TO BRUISE 8 0.0009
524 HAEMATEMESIS 22 0.0009
525 INTERSTITIAL LUNG DISEASE 42 0.0009
526 GRAND MAL CONVULSION 8 0.0009
527 ANXIETY 244 0.0009
528 HYPERKALAEMIA 30 0.0009
529 FEAR 23 0.0009
530 STEVENS-JOHNSON SYNDROME 19 0.0009
531 FLANK PAIN 8 0.0009
532 EYE DISORDER 28 0.0009
533 LYMPHOPENIA 12 0.0008
534 HYPERHIDROSIS 109 0.0008
535 FOOT FRACTURE 16 0.0008
536 GASTRIC ULCER 16 0.0008
537 CEREBROVASCULAR ACCIDENT 142 0.0008
538 RECTAL HAEMORRHAGE 36 0.0008
539 ANHEDONIA 22 0.0008
540 OXYGEN SATURATION DECREASED 47 0.0008
541 BASAL CELL CARCINOMA 13 0.0008
542 PRURITUS GENERALISED 18 0.0008
543 MYOCARDIAL INFARCTION 145 0.0008
544 OSTEOARTHRITIS 35 0.0008
545 RESTLESS LEGS SYNDROME 15 0.0008
546 HYPERGLYCAEMIA 30 0.0008
547 EAR PAIN 16 0.0008
548 STAPHYLOCOCCAL INFECTION 27 0.0008
549 ANAEMIA 156 0.0008
550 TOOTH FRACTURE 9 0.0008
551 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
552 ABDOMINAL PAIN UPPER 167 0.0008
553 MYOPATHY 7 0.0008
554 CARDIAC FAILURE 65 0.0008
555 DEPRESSED LEVEL OF CONSCIOUSNESS 32 0.0008
556 PNEUMONITIS 22 0.0008
557 CONSTIPATION 176 0.0008
558 COMA 38 0.0008
559 CARDIAC ARREST 65 0.0008
560 VENTRICULAR TACHYCARDIA 13 0.0008
561 LOCALISED INFECTION 19 0.0008
562 TOOTH ABSCESS 8 0.0008
563 LIPASE INCREASED 6 0.0008
564 CHOLESTASIS 15 0.0008
565 HEPATIC ENZYME INCREASED 53 0.0008
566 URINARY INCONTINENCE 23 0.0008
567 ANAPHYLACTIC SHOCK 20 0.0008
568 TOOTHACHE 14 0.0008
569 APNOEA 6 0.0008
570 HEART RATE DECREASED 27 0.0008
571 SPLENOMEGALY 9 0.0008
572 BACK PAIN 178 0.0008
573 INSOMNIA 204 0.0008
574 TOOTH DISORDER 17 0.0008
575 CONDITION AGGRAVATED 232 0.0008
576 WEIGHT DECREASED 212 0.0008
577 DIVERTICULITIS 21 0.0008
578 OROPHARYNGEAL PAIN 70 0.0008
579 HEADACHE 474 0.0008
580 VISUAL ACUITY REDUCED 25 0.0008
581 DIARRHOEA HAEMORRHAGIC 7 0.0007
582 CARDIOVASCULAR DISORDER 19 0.0007
583 CONTUSION 72 0.0007
584 LOCAL SWELLING 13 0.0007
585 HYPERSENSITIVITY 138 0.0007
586 LOSS OF CONSCIOUSNESS 95 0.0007
587 BLOOD BILIRUBIN INCREASED 20 0.0007
588 INJURY 52 0.0007
589 BLOOD PRESSURE INCREASED 113 0.0007
590 NO THERAPEUTIC RESPONSE 9 0.0007
591 DIZZINESS 368 0.0007
592 SKIN LACERATION 8 0.0007
593 DRUG INTERACTION 116 0.0007
594 WOUND INFECTION 8 0.0007
595 ESCHERICHIA INFECTION 6 0.0007
596 ABNORMAL WEIGHT GAIN 9 0.0007
597 DEAFNESS 19 0.0007
598 UNDERDOSE 53 0.0007
599 BLOOD COUNT ABNORMAL 11 0.0007
600 STOMATITIS 44 0.0007
601 INFUSION RELATED REACTION 48 0.0007
602 TOOTH LOSS 15 0.0007
603 HEPATIC FUNCTION ABNORMAL 27 0.0007
604 LIVER DISORDER 32 0.0007
605 MENTAL STATUS CHANGES 20 0.0007
606 POLLAKIURIA 30 0.0007
607 HYPOMAGNESAEMIA 10 0.0007
608 VITAMIN D DEFICIENCY 7 0.0007
609 DEPRESSION 163 0.0007
610 HAEMODIALYSIS 6 0.0007
611 HEPATOMEGALY 7 0.0007
612 VITREOUS FLOATERS 7 0.0007
613 INABILITY TO AFFORD MEDICATION 7 0.0007
614 INTRAOCULAR PRESSURE INCREASED 9 0.0007
615 DERMATITIS CONTACT 8 0.0007
616 GENERAL PHYSICAL HEALTH DETERIORATION 81 0.0007
617 PARALYSIS 10 0.0007
618 CEREBRAL INFARCTION 17 0.0007
619 RHABDOMYOLYSIS 29 0.0007
620 PYREXIA 240 0.0007
621 VISION BLURRED 95 0.0007
622 MALAISE 303 0.0007
623 DYSKINESIA 28 0.0007
624 ELECTROLYTE IMBALANCE 8 0.0007
625 SUBARACHNOID HAEMORRHAGE 7 0.0007
626 FLUID OVERLOAD 10 0.0007
627 SENSORY DISTURBANCE 11 0.0007
628 TOOTH INFECTION 9 0.0007
629 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
630 DISORIENTATION 27 0.0007
631 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
632 BLOOD POTASSIUM INCREASED 11 0.0007
633 POST PROCEDURAL COMPLICATION 13 0.0007
634 SWELLING FACE 44 0.0007
635 CHOLECYSTITIS 8 0.0007
636 BALANCE DISORDER 58 0.0007
637 SPEECH DISORDER 35 0.0007
638 AGITATION 49 0.0007
639 SCRATCH 7 0.0007
640 SEPSIS 74 0.0007
641 RENAL FAILURE 88 0.0007
642 TACHYPNOEA 9 0.0007
643 NASOPHARYNGITIS 122 0.0007
644 MENTAL IMPAIRMENT 16 0.0007
645 INFLAMMATION 34 0.0007
646 LUNG NEOPLASM MALIGNANT 27 0.0007
647 SINUS DISORDER 13 0.0007
648 RESTLESSNESS 24 0.0007
649 MOVEMENT DISORDER 21 0.0007
650 CIRCULATORY COLLAPSE 11 0.0006
651 TENDONITIS 10 0.0006
652 CYST 8 0.0006
653 ERYTHEMA MULTIFORME 6 0.0006
654 SWELLING 60 0.0006
655 SYNCOPE 64 0.0006
656 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
657 JOINT SWELLING 77 0.0006
658 BLOOD GLUCOSE INCREASED 120 0.0006
659 DYSPHAGIA 60 0.0006
660 GAMMA-GLUTAMYLTRANSFERASE INCREASED 14 0.0006
661 FOOT DEFORMITY 7 0.0006
662 LIP SWELLING 21 0.0006
663 ASTHENIA 237 0.0006
664 TRANSAMINASES INCREASED 14 0.0006
665 NASAL CONGESTION 37 0.0006
666 ABDOMINAL PAIN 146 0.0006
667 ERECTILE DYSFUNCTION 16 0.0006
668 SEPTIC SHOCK 27 0.0006
669 ERUCTATION 12 0.0006
670 RHINORRHOEA 40 0.0006
671 MUSCULOSKELETAL STIFFNESS 54 0.0006
672 GALLBLADDER DISORDER 11 0.0006
673 AUTOIMMUNE DISORDER 6 0.0006
674 BONE PAIN 36 0.0006
675 CHOLECYSTECTOMY 7 0.0006
676 MEDICATION ERROR 34 0.0006
677 SOMNOLENCE 123 0.0006
678 DYSPEPSIA 60 0.0006
679 OSTEONECROSIS 20 0.0006
680 NIGHTMARE 21 0.0006
681 IRRITABLE BOWEL SYNDROME 13 0.0006
682 OSTEONECROSIS OF JAW 15 0.0006
683 LIVER FUNCTION TEST INCREASED 13 0.0006
684 BLADDER DISORDER 6 0.0006
685 UPPER LIMB FRACTURE 12 0.0006
686 EYELID OEDEMA 7 0.0006
687 RENAL DISORDER 28 0.0006
688 FAECES DISCOLOURED 13 0.0006
689 BRAIN INJURY 6 0.0006
690 ANAPHYLACTIC REACTION 33 0.0006
691 MOOD SWINGS 19 0.0006
692 METABOLIC ACIDOSIS 19 0.0006
693 LYMPHADENOPATHY 21 0.0006
694 EXTRA DOSE ADMINISTERED 24 0.0006
695 AGRANULOCYTOSIS 11 0.0006
696 VERTIGO 36 0.0006
697 MUSCULAR WEAKNESS 67 0.0006
698 DRUG DOSE OMISSION 97 0.0006
699 ACCIDENT 7 0.0006
700 DEEP VEIN THROMBOSIS 38 0.0006
701 HAEMOGLOBIN DECREASED 60 0.0006
702 SKIN LESION 16 0.0006
703 BLOOD PRESSURE FLUCTUATION 14 0.0006
704 CHOLELITHIASIS 19 0.0006
705 RASH GENERALISED 15 0.0006
706 DEHYDRATION 77 0.0006
707 DRUG EFFECT DECREASED 31 0.0006
708 EPISTAXIS 43 0.0006
709 HYPOAESTHESIA 86 0.0006
710 URINARY TRACT INFECTION 98 0.0006
711 INFLUENZA 64 0.0006
712 ROAD TRAFFIC ACCIDENT 24 0.0006
713 DERMATITIS 12 0.0006
714 CARPAL TUNNEL SYNDROME 8 0.0006
715 OVERDOSE 123 0.0006
716 INCONTINENCE 6 0.0006
717 BLINDNESS UNILATERAL 8 0.0006
718 EYE PRURITUS 19 0.0006
719 IRRITABILITY 34 0.0006
720 SHOCK 13 0.0006
721 ABSCESS 9 0.0006
722 MUSCLE TWITCHING 13 0.0006
723 HAEMORRHOIDS 11 0.0006
724 THROMBOCYTOPENIA 63 0.0006
725 ILEUS 7 0.0006
726 EXPOSURE DURING PREGNANCY 35 0.0006
727 BODY HEIGHT DECREASED 6 0.0006
728 AGGRESSION 28 0.0006
729 DECREASED ACTIVITY 6 0.0006
730 MUSCLE TIGHTNESS 9 0.0006
731 CHILLS 65 0.0006
732 PRODUCT USE ISSUE 104 0.0006
733 AMNESIA 36 0.0006
734 PARAESTHESIA 87 0.0006
735 BLISTER 31 0.0006
736 PALLOR 15 0.0006
737 FEMUR FRACTURE 17 0.0005
738 GASTROENTERITIS 8 0.0005
739 MANIA 9 0.0005
740 FLATULENCE 31 0.0005
741 TINNITUS 25 0.0005
742 ABNORMAL DREAMS 15 0.0005
743 HAEMATOMA 14 0.0005
744 FUNGAL INFECTION 18 0.0005
745 ARTHROPATHY 30 0.0005
746 CONJUNCTIVITIS 10 0.0005
747 LETHARGY 31 0.0005
748 GAIT INABILITY 18 0.0005
749 VOMITING 253 0.0005
750 CYSTITIS 17 0.0005
751 FISTULA 6 0.0005
752 FACE OEDEMA 9 0.0005
753 BLOOD CALCIUM DECREASED 6 0.0005
754 HYPOCALCAEMIA 10 0.0005
755 NIGHT SWEATS 17 0.0005
756 ABASIA 13 0.0005
757 PAIN IN EXTREMITY 155 0.0005
758 EXTRAPYRAMIDAL DISORDER 13 0.0005
759 DRUG DISPENSING ERROR 8 0.0005
760 ERYTHEMA 107 0.0005
761 SINUS CONGESTION 7 0.0005
762 HERNIA 10 0.0005
763 CAESAREAN SECTION 6 0.0005
764 URTICARIA 86 0.0005
765 GINGIVAL BLEEDING 7 0.0005
766 TREATMENT NONCOMPLIANCE 28 0.0005
767 POOR QUALITY SLEEP 11 0.0005
768 PANCREATITIS 27 0.0005
769 PERIPHERAL COLDNESS 7 0.0005
770 KIDNEY INFECTION 10 0.0005
771 NAUSEA 403 0.0005
772 DISABILITY 10 0.0005
773 HALLUCINATION, AUDITORY 8 0.0005
774 WOUND 14 0.0005
775 WEIGHT INCREASED 112 0.0005
776 HIP FRACTURE 16 0.0005
777 APHASIA 15 0.0005
778 BLOOD PRESSURE DECREASED 33 0.0005
779 MUCOSAL INFLAMMATION 13 0.0005
780 CONFUSIONAL STATE 80 0.0005
781 PAIN IN JAW 14 0.0005
782 PANIC ATTACK 18 0.0005
783 DIALYSIS 7 0.0005
784 SUICIDAL IDEATION 45 0.0005
785 PRODUCT DOSE OMISSION 32 0.0005
786 EAR INFECTION 13 0.0005
787 HYPERCALCAEMIA 6 0.0005
788 DRUG LEVEL INCREASED 8 0.0005
789 HEPATIC STEATOSIS 9 0.0005
790 THINKING ABNORMAL 9 0.0005
791 HYPOKINESIA 7 0.0005
792 FALL 160 0.0005
793 HYPOTENSION 96 0.0005
794 DYSARTHRIA 18 0.0005
795 INFECTION 69 0.0005
796 UPPER GASTROINTESTINAL HAEMORRHAGE 8 0.0005
797 DISCOMFORT 29 0.0005
798 KNEE ARTHROPLASTY 10 0.0005
799 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
800 THERAPEUTIC RESPONSE UNEXPECTED 21 0.0005
801 IMPAIRED WORK ABILITY 10 0.0005
802 FEELING ABNORMAL 112 0.0005
803 C-REACTIVE PROTEIN INCREASED 17 0.0005
804 PAIN 286 0.0005
805 DEMENTIA 13 0.0005
806 ACCIDENTAL OVERDOSE 17 0.0005
807 HYPOAESTHESIA ORAL 7 0.0005
808 RASH PRURITIC 25 0.0005
809 EYE PAIN 26 0.0005
810 DRY EYE 23 0.0005
811 ECZEMA 24 0.0005
812 RASH MACULAR 16 0.0005
813 AMENORRHOEA 8 0.0005
814 FATIGUE 355 0.0005
815 IMMUNE SYSTEM DISORDER 6 0.0005
816 ADVERSE REACTION 6 0.0005
817 FIBROMYALGIA 11 0.0005
818 DRUG ERUPTION 8 0.0005
819 RHEUMATOID ARTHRITIS 51 0.0004
820 SPINAL FRACTURE 9 0.0004
821 DIARRHOEA 289 0.0004
822 CHRONIC KIDNEY DISEASE 34 0.0004
823 PANCYTOPENIA 25 0.0004
824 RASH PAPULAR 10 0.0004
825 SNEEZING 10 0.0004
826 GAIT DISTURBANCE 85 0.0004
827 LIMB INJURY 12 0.0004
828 BLINDNESS 18 0.0004
829 DRUG EFFECT INCOMPLETE 16 0.0004
830 MATERNAL EXPOSURE DURING PREGNANCY 39 0.0004
831 ILLNESS 45 0.0004
832 MENTAL DISORDER 19 0.0004
833 FEELING COLD 12 0.0004
834 HUNGER 6 0.0004
835 BACK DISORDER 7 0.0004
836 EYE SWELLING 16 0.0004
837 PHOTOPHOBIA 8 0.0004
838 COLITIS 16 0.0004
839 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 30 0.0004
840 EXPIRED PRODUCT ADMINISTERED 14 0.0004
841 HAEMORRHAGE 44 0.0004
842 PROTEINURIA 8 0.0004
843 INCREASED APPETITE 8 0.0004
844 HAEMATOCHEZIA 23 0.0004
845 LOWER LIMB FRACTURE 8 0.0004
846 ALTERED STATE OF CONSCIOUSNESS 9 0.0004
847 NEPHROLITHIASIS 19 0.0004
848 DYSTONIA 8 0.0004
849 TREATMENT FAILURE 34 0.0004
850 JAUNDICE 11 0.0004
851 MIGRAINE 39 0.0004
852 DISTURBANCE IN ATTENTION 22 0.0004
853 RASH MACULO-PAPULAR 9 0.0004
854 RENAL INJURY 12 0.0004
855 SKIN EXFOLIATION 34 0.0004
856 MEMORY IMPAIRMENT 55 0.0004
857 HERPES ZOSTER 23 0.0004
858 PREGNANCY 8 0.0004
859 RASH 174 0.0004
860 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
861 THIRST 7 0.0004
862 HEPATITIS 10 0.0004
863 PRURITUS 150 0.0004
864 TARDIVE DYSKINESIA 11 0.0004
865 DEVICE RELATED INFECTION 6 0.0004
866 SKIN DISORDER 13 0.0004
867 EMOTIONAL DISORDER 12 0.0004
868 EMOTIONAL DISTRESS 47 0.0004
869 ANKLE FRACTURE 6 0.0004
870 ARTHRALGIA 161 0.0004
871 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
872 DYSSTASIA 11 0.0004
873 EATING DISORDER 8 0.0004
874 FEELING HOT 23 0.0004
875 PSYCHOTIC DISORDER 11 0.0004
876 GASTROINTESTINAL HAEMORRHAGE 31 0.0004
877 HEPATIC FAILURE 11 0.0004
878 DRUG PRESCRIBING ERROR 7 0.0004
879 MELAENA 8 0.0004
880 VISUAL IMPAIRMENT 45 0.0004
881 COAGULOPATHY 6 0.0004
882 ALOPECIA 70 0.0004
883 ADVERSE DRUG REACTION 32 0.0004
884 PANCREATITIS ACUTE 8 0.0004
885 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 64 0.0004
886 INFLUENZA LIKE ILLNESS 29 0.0004
887 BLOOD PRESSURE ABNORMAL 7 0.0004
888 GASTRIC DISORDER 12 0.0003
889 UNRESPONSIVE TO STIMULI 9 0.0003
890 HEAD INJURY 11 0.0003
891 HOT FLUSH 26 0.0003
892 INTESTINAL OBSTRUCTION 13 0.0003
893 BONE MARROW FAILURE 7 0.0003
894 JOINT STIFFNESS 9 0.0003
895 IMPAIRED HEALING 11 0.0003
896 CRYING 12 0.0003
897 EYE IRRITATION 19 0.0003
898 SUICIDE ATTEMPT 20 0.0003
899 ACUTE KIDNEY INJURY 50 0.0003
900 SKIN CANCER 7 0.0003
901 PROCEDURAL PAIN 9 0.0003
902 LEUKOPENIA 16 0.0003
903 RED BLOOD CELL COUNT DECREASED 9 0.0003
904 DEATH 271 0.0003
905 PSORIASIS 41 0.0003
906 PLATELET COUNT DECREASED 33 0.0003
907 DRUG WITHDRAWAL SYNDROME 27 0.0003
908 SKIN DISCOLOURATION 14 0.0003
909 ABNORMAL BEHAVIOUR 12 0.0003
910 PRODUCT DOSE OMISSION ISSUE 88 0.0003
911 PAIN OF SKIN 8 0.0003
912 ANGER 10 0.0003
913 MOOD ALTERED 8 0.0003
914 HALLUCINATION 22 0.0003
915 BLOOD GLUCOSE DECREASED 14 0.0003
916 DECREASED APPETITE 67 0.0003
917 PRESYNCOPE 7 0.0003
918 INTENTIONAL DRUG MISUSE 6 0.0003
919 PRODUCT USE IN UNAPPROVED INDICATION 71 0.0003
920 ABDOMINAL DISCOMFORT 48 0.0003
921 HALLUCINATION, VISUAL 6 0.0003
922 PNEUMONIA ASPIRATION 7 0.0003
923 GASTROINTESTINAL DISORDER 25 0.0003
924 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
925 ABDOMINAL PAIN LOWER 7 0.0003
926 FLUSHING 28 0.0003
927 LIVER FUNCTION TEST ABNORMAL 8 0.0003
928 OCULAR HYPERAEMIA 13 0.0003
929 PROSTATE CANCER 22 0.0003
930 SURGERY 16 0.0003
931 MULTIPLE SCLEROSIS 13 0.0003
932 BREAST CANCER 25 0.0003
933 HOSPITALISATION 41 0.0003
934 EPILEPSY 8 0.0003
935 BURNING SENSATION 18 0.0003
936 FEBRILE NEUTROPENIA 17 0.0003
937 SYSTEMIC LUPUS ERYTHEMATOSUS 9 0.0003
938 THERAPY CESSATION 13 0.0003
939 OFF LABEL USE 221 0.0003
940 SEIZURE 29 0.0003
941 RENAL IMPAIRMENT 21 0.0002
942 DEPRESSED MOOD 13 0.0002
943 NEUTROPHIL COUNT DECREASED 10 0.0002
944 ENCEPHALOPATHY 6 0.0002
945 INTENTIONAL PRODUCT USE ISSUE 21 0.0002
946 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
947 PREMATURE BABY 7 0.0002
948 DELIRIUM 8 0.0002
949 ANGIOEDEMA 10 0.0002
950 BREAST CANCER FEMALE 6 0.0002
951 NERVOUS SYSTEM DISORDER 7 0.0002
952 ACNE 17 0.0002
953 THERAPY NON-RESPONDER 10 0.0002
954 WITHDRAWAL SYNDROME 9 0.0002
955 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
956 INTENTIONAL DOSE OMISSION 6 0.0002
957 NEOPLASM MALIGNANT 14 0.0002
958 HYPOACUSIS 9 0.0002
959 PERIPHERAL SWELLING 32 0.0002
960 NEUTROPENIA 28 0.0002
961 DEVICE MALFUNCTION 14 0.0002
962 UNEVALUABLE EVENT 15 0.0002
963 DISEASE PROGRESSION 23 0.0002
964 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
965 BONE DENSITY DECREASED 6 0.0002
966 PRODUCT SUBSTITUTION ISSUE 11 0.0002
967 INJECTION SITE PAIN 55 0.0002
968 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
970 COGNITIVE DISORDER 8 0.0002
971 INJECTION SITE ERYTHEMA 21 0.0002
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 6 0.0002
973 MOBILITY DECREASED 12 0.0002
974 INJECTION SITE HAEMORRHAGE 13 0.0002
975 COLITIS ULCERATIVE 7 0.0002
976 SKIN IRRITATION 7 0.0002
977 ABORTION SPONTANEOUS 6 0.0001
978 COVID-19 26 0.0001
979 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
980 INCORRECT DOSE ADMINISTERED 33 0.0001
981 DRUG DEPENDENCE 23 0.0001
982 INTENTIONAL OVERDOSE 9 0.0001
983 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
984 INJECTION SITE SWELLING 10 0.0001
985 DRY SKIN 17 0.0001
986 COMPLETED SUICIDE 10 0.0001
987 INJECTION SITE PRURITUS 8 0.0001
988 SKIN BURNING SENSATION 8 0.0001
989 TOXICITY TO VARIOUS AGENTS 18 0.0001
990 INJECTION SITE REACTION 7 0.0001
991 INJECTION SITE BRUISING 8 0.0001
992 FOETAL EXPOSURE DURING PREGNANCY 7 0.0001
993 DEVICE ISSUE 7 0.0001
994 DRUG ABUSE 6 0.0001
995 NO ADVERSE EVENT 8 0.0000